Caribou Bio Secures $115M to Advance CRISPR Platform and Allogeneic Cell Therapy Pipeline
Caribou Biosciences announced the successful completion of an oversubscribed $115 million Series C financing, co-led by new premier healthcare investors […]
Caribou Biosciences announced the successful completion of an oversubscribed $115 million Series C financing, co-led by new premier healthcare investors […]
A new biotech venture called Ensoma was launched just recently, in conjunction with a sizable $70 million Series A funding […]
The City of Hope now seeks patients for a Phase 1 clinical trial centering on an investigational vaccine that uses […]
A painful inherited blood disorder affecting millions of people, especially Black people, occurs because of a deficiency of red blood […]
French pharmaceutical giant Sanofi has made an offer to acquire Kiadis, a clinical-stage biotech company developing what they refer to […]
An international team of researchers led by Professor Rejko Krüger, of Luxembourg Centre for Systems Biomedicine (LCSB) of the University […]
Two prominent researchers from the Saban Research Institute of Children’s Hospital Los Angeles haves secured over $4 million from the […]
Seattle’s Infectious Disease Research Institute, a nonprofit organization, reports positive early results from a clinical trial centering on the use […]
UNC Lineberger Comprehensive Cancer Center and Baylor College of Medicine in Houston have completed an early phase clinical trial showcasing […]
With rapid growth of cell and gene therapy development comes shortages and bottlenecks the require specialized manufacturing capability associated with […]